STOCK TITAN

Falcon Creek group discloses major Cingulate (CING) stakes up to 19.9%

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Falcon Creek Capital Advisor LLC and affiliated funds disclosed significant ownership stakes in Cingulate Inc. common stock. Falcon Creek Capital Advisor reports beneficial ownership of 2,073,957 shares, representing 19.9% of the outstanding common stock. Falcon Creek Technology Fund I reports 350,195 shares, or 3.3%, and Ginkgo Capital Global Fund SPC – Xtalpi AI Fund reports 1,723,763 shares, or 16.6%. The stake arises from securities acquired under a Securities Purchase Agreement dated January 27, 2026, with related warrants and agreements referenced in multiple exhibits.

Positive

  • None.

Negative

  • None.

Insights

New Schedule 13D shows a concentrated holder with nearly 20% of Cingulate.

The filing indicates that Falcon Creek Capital Advisor LLC beneficially owns 2,073,957 Cingulate common shares, stated as 19.9% of the class. Related vehicles, including Falcon Creek Technology Fund I and Ginkgo Capital Global Fund SPC – Xtalpi AI Fund, also report sizable positions.

This level of ownership can be influential in shareholder votes and strategic matters, especially if the interests of these reporting persons are aligned. The positions are tied to a Securities Purchase Agreement dated January 27, 2026 and associated warrants and assignments described in the exhibits.

Future company disclosures may clarify how these investors engage with Cingulate’s board and management, and whether their investment remains passive or becomes more actively involved in corporate actions.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
See Item 5 below.


SCHEDULE 13D




Comment for Type of Reporting Person:
See Item 5 below.


SCHEDULE 13D




Comment for Type of Reporting Person:
See Item 5 below.


SCHEDULE 13D


Falcon Creek Capital Advisor LLC
Signature:/s/ Zhangpeng Jiang
Name/Title:President
Date:02/09/2026
Falcon Creek Technology Fund I, LP
Signature:/s/ Zhangpeng Jiang
Name/Title:Managing Partner
Date:02/09/2026
Ginkgo Capital Global Fund SPC - Xtalpi AI Fund SP
Signature:/s/ Zhangpeng Jiang
Name/Title:Investment Manager
Date:02/09/2026

FAQ

What ownership stake in Cingulate Inc. does Falcon Creek Capital Advisor report?

Falcon Creek Capital Advisor LLC reports beneficial ownership of 2,073,957 shares of Cingulate Inc. common stock, representing 19.9% of the outstanding class. This sizable stake gives the adviser significant influence potential in shareholder matters and is disclosed in a Schedule 13D filing.

How many Cingulate (CING) shares does Falcon Creek Technology Fund I hold?

Falcon Creek Technology Fund I reports beneficial ownership of 350,195 Cingulate common shares, representing 3.3% of the class. The fund’s principal business is holding venture capital and private equity investments, mostly in the technology sector, as disclosed in the filing.

What is Ginkgo Capital Global Fund SPC – Xtalpi AI Fund’s stake in Cingulate (CING)?

Ginkgo Capital Global Fund SPC – Xtalpi AI Fund reports beneficial ownership of 1,723,763 shares of Cingulate common stock, equal to 16.6% of the class. The fund holds a broad portfolio of public and private equities, including this significant Cingulate position.

What transaction led to Falcon Creek’s and Ginkgo’s Cingulate share acquisitions?

The filing states that the only transaction in Cingulate common stock in the past 60 days was acquiring securities under a Securities Purchase Agreement dated January 27, 2026. Related warrants and assignment agreements are detailed in the listed exhibits to the Schedule 13D.

Are Falcon Creek and Ginkgo involved in any securities law proceedings related to Cingulate?

The reporting persons state that, over the past five years, none has been convicted in criminal proceedings or been subject to civil judgments or orders involving federal or state securities law violations. This disclosure covers Falcon Creek entities and Ginkgo Capital Global Fund SPC.

What is the business focus of the Falcon Creek and Ginkgo entities holding Cingulate shares?

Falcon Creek Capital Advisor operates as an advisory firm specializing in venture investments. Falcon Creek Technology Fund I focuses on venture capital and private equity, mostly technology, while Ginkgo Capital Global Fund SPC holds a diversified portfolio spanning public and private equity investments.
Cingulate Inc

NASDAQ:CING

CING Rankings

CING Latest News

CING Latest SEC Filings

CING Stock Data

48.92M
9.39M
1.81%
5.27%
4.25%
Biotechnology
Pharmaceutical Preparations
Link
United States
KANSAS CITY